• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bristol-Myers Confident with on-time OK of Celgene deal in Europe

Share:

July 29, 2019

  • Bristol-Myers Squibb (BMY +0.2%) expects a timely sign-off from the European Commission (EC) regarding its takeover of Celgene (CELG +0.5%), adding that the conclusion of the EC’s Phase 1 review is set for July 29.
  • BMY has agreed to divest CELG’s Otezla (apremilast) in order to receive a timely thumbs-up in the U.S.

Date: July 29, 2019

Source: <span style=”color: #000000;”><a style=”color: #000000;” href=”https://seekingalpha.com/news/3480406-bristol-myers-confident-time-ok-celgene-deal-europe” target=”_blank” rel=”noopener noreferrer”>Seeking Alpha</a></span>

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • JPMorgan Poised To Reap Record Fee For Allergan Deal – FTJPMorgan Poised To Reap Record Fee For Allergan Deal – FT
  • Pharmaceutical Excipients Market with COVID-19 Impact Analysis, Global Industry Analysis, Growth Opportunities, Detailed Overview and 2026 Forecast StudyPharmaceutical Excipients Market with COVID-19 Impact Analysis, Global Industry Analysis, Growth Opportunities, Detailed Overview and 2026 Forecast Study
  • Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human SubjectsTiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects
  • Northwell Health Offers COVID-19 Screening Chat for NY Schools and EmployersNorthwell Health Offers COVID-19 Screening Chat for NY Schools and Employers
  • Virtual Behavioral Health Company Valera Health Scores $44.5MVirtual Behavioral Health Company Valera Health Scores $44.5M
  • The Smart Care of the FutureThe Smart Care of the Future
  • Public Health Officials Talk About What Innovators Need to Know During COVID-19 CrisisPublic Health Officials Talk About What Innovators Need to Know During COVID-19 Crisis
  • Apple’s 2019 in Review: Research Programs, Health Records, Patents and FeaturesApple’s 2019 in Review: Research Programs, Health Records, Patents and Features

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications